BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23458521)

  • 21. Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years.
    Wong GL; Wong VW; Chan HY; Tse PC; Wong J; Chim AM; Yiu KK; Chu SH; Chan HL
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1326-35. PubMed ID: 22506552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
    Li J; Jia M; Liu Y; She W; Li L; Wang J; Jiang W
    Liver Int; 2015 Mar; 35(3):834-45. PubMed ID: 24814578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of kurarinol on peripheral blood CTL surface PD-1 expression of patients with chronic hepatitis B].
    Zhu YF; Gu XB; Yang XJ; Hua Z; Lu ZH; Zang B; Wu HY; Jiang YM; Chen HK; Pei H; Xu YQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):446-9. PubMed ID: 23627026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
    Liu F; Chen L; Yu DM; Deng L; Chen R; Jiang Y; Chen L; Huang SY; Yu JL; Gong QM; Zhang XX
    Gut; 2011 Sep; 60(9):1269-77. PubMed ID: 21292683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X; Yan HP; Liao HY; Liu YM; Huang YL; Zhang GY; Lin F; Zhang X; Zhao Y; Zhang HP; Wang S; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):739-42. PubMed ID: 22781352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating PD-1
    Zhang L; Li H; Ren H; Hu P
    Mol Immunol; 2018 Nov; 103():270-278. PubMed ID: 30340072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.
    Shin JW; Jung SW; Park BR; Kim CJ; Eum JB; Kim BG; Du Jeong I; Bang SJ; Park NH
    Antivir Ther; 2012; 17(2):387-94. PubMed ID: 22293395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.
    Nan XP; Zhang Y; Yu HT; Sun RL; Peng MJ; Li Y; Su WJ; Lian JQ; Wang JP; Bai XF
    Viral Immunol; 2012 Feb; 25(1):21-8. PubMed ID: 22233255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
    You H; Wu X; Ou X; Ma H; Wang Q; Liu T; Cong M; Wang P; Wang B; Jia J
    Antivir Ther; 2011; 16(3):299-307. PubMed ID: 21555812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
    Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telbivudine treatment in chronic hepatitis B: experience from China.
    You H; Jia J
    J Viral Hepat; 2013 Apr; 20 Suppl 1():3-8. PubMed ID: 23458519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementarity-determining region 3 size spectratypes of T cell receptor beta chains in CD8+ T cells following antiviral treatment of chronic hepatitis B.
    Ma SW; Li YY; Zhang GW; Huang X; Sun J; Li C; Abbott WG; Hou JL
    Antimicrob Agents Chemother; 2011 Feb; 55(2):888-94. PubMed ID: 21098256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
    Gu Y; Lian Y; Gu L; Chen L; Li X; Zhou L; Huang Y; Wang J; Huang Y
    BMC Infect Dis; 2019 Mar; 19(1):216. PubMed ID: 30832595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.